Transfusion not always best treatment for anemia, age of stored blood may play a role

University of Kentucky researchers, including lead author Samy Selim of the Division of Cardiovascular Medicine and the Saha Cardiovascular Research Center, have recently published a paper suggesting that transfusion may not always be the best treatment for hospitalized patients with anemia. Results suggest the age of stored blood may be a factor in negative effects of transfusion.

The paper, " of sphingosine l-phosphate are strongly correlated with haemotocrit, but variably restored by transfusions," appeared in a recent edition of the journal Clinical Science.

For many years, the traditional treatment for hospitalized patients in the United States who have developed anemia — whether associated with medical illness, surgical procedures or trauma — has been red blood cell transfusion, despite the absence of supporting data in many patient populations.

While still a life-saving measure in emergency situations such as acute bleeding, emerging evidence suggests that transfusions may, in fact, be associated with risk beyond commonly-held concerns of microbial transmission and acute reactions. Researchers are currently trying to understand the mechanism behind this observed deleterious effect of transfusion, which seems to correlate with the duration of storage of blood (blood for transfusion may currently be stored up to 42 days).

Red blood cells carry and deliver an important biologically active lipid mediator, sphingosine 1-phosphate (S1P), which is required for maintaining the integrity of blood vessels.

In the study, investigators confirmed that individuals with anemia have lower circulating levels of S1P. They found that transfusion to correct does not always restore levels of S1P and the inability to restore S1P may be associated with the age of the transfused blood. Levels of S1P decrease during storage of red blood cells, which may explain why transfusion of older blood is less able to restore S1P levels.

These findings could help to explain some of the reasons that blood transfusions can have adverse consequences. Future efforts may focus on supplementing red blood cells with S1P in an attempt to improve outcomes in .

Provided by University of Kentucky

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

US orders farms to report pig virus infections

15 hours ago

The U.S. government is starting a new program to help monitor and possibly control the spread of a virus that has killed millions of pigs since showing up in the country last year.

Foreigner dies of MERS in Saudi

16 hours ago

A foreigner has died after she contracted MERS in the Saudi capital, the health ministry said on announced Friday, bringing the nationwide death toll to 73.

Vietnam battles fatal measles outbreak

19 hours ago

Vietnam is scrambling to contain a deadly outbreak of measles that has killed more than 100 people, mostly young children, and infected thousands more this year, the government said Friday.

New clues on tissue scarring in scleroderma

20 hours ago

A discovery by Northwestern Medicine scientists could lead to potential new treatments for breaking the cycle of tissue scarring in people with scleroderma.

User comments